VDR favors FoxP3+ T reg cells, which prevent the development of experimental colitis through the production of inhibitory cytokines such as IL-10 and TGF-β [77] and FoxP3+ T reg cells are induced by 1,25(OH)2D3 treatments in vitro and in vivo [78]. The gene discussed is FOXP3; the disease is colitis.